Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Motorola Solutions Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Motorola Solutions Inc trades at $449.41 (market cap $74.31B). The key difference: Motorola Solutions Inc is far larger — about 8.4× Kymera Therapeutics Inc. Common Stock's market cap, and Motorola Solutions Inc pays a 1.08% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Motorola Solutions Inc for 101 Days on average.
| KYMR | MSI | |
|---|---|---|
Market Cap | $8.87B | $74.31B |
Volume | 779,107 | 847,711 |
Sector | Health | Technology |
52-Week High | $127.31 | $491.24 |
52-Week Low | $55.80 | $363.83 |
Typical Hold Time | 0 Days | 101 Days |
Enterprise Value | $8.26B | $83.22B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Motorola Solutions (MSI) trades at $451.49, up 1.19% with a neutral technical outlook. The stock shows strong fundamentals with consistent earnings beats, a record $15.6B backlog (Zacks, 2026-09-28), and robust profitability (17.44% net margin). Recent acquisitions like D-Fend Solutions expand its security footprint, while a $2B share repurchase boost signals confidence. Valuation ratios remain elevated with P/E at 35.38.
Outlook is positive driven by contract wins and AI integration, but high valuation and significant investing cash outflows ($-5.16B in 2025) pose risks. Analyst consensus is bullish (70.59% Buy) with a $525.86 price target, implying 16% upside. Key risks include execution of acquisitions and debt levels (debt-to-asset 47.29% in 2025).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
